LG 101506: Precision RXR Modulator for Nuclear Receptor Signaling Research

Executive Summary: LG 101506 is a small molecule Retinoid X Receptor (RXR) modulator featuring 98% purity and robust solubility in DMSO and ethanol (APExBIO). It is designed for use in RXR signaling pathway research, including studies on metabolism, immune checkpoints, and nuclear receptor-related disease models (Zhang et al., 2022). The compound is strictly for research use, shipped with temperature control, and requires storage at -20°C to maintain stability. LG 101506 enables reproducible chemical biology experiments by offering a defined molecular weight (420.53 Da) and validated chemical identity. Its role in dissecting RXR-dependent transcriptional and post-translational control is critical for understanding cancer biology and metabolic regulation (related article).

Biological Rationale

The Retinoid X Receptor (RXR) is a nuclear receptor that regulates gene expression in response to ligands. RXR forms heterodimers with other nuclear receptors, influencing pathways in metabolism, immunity, and cellular differentiation (Zhang et al., 2022). RXR signaling is implicated in the regulation of programmed death ligand-1 (PD-L1), a checkpoint molecule exploited by cancer cells for immune evasion. Targeting RXR can modulate transcriptional networks that influence PD-L1 expression and T cell infiltration in tumors, especially in immune-cold environments such as triple-negative breast cancer (TNBC) (Zhang et al., 2022). LG 101506 provides a reliable tool for probing these pathways, allowing researchers to dissect the cross-talk between nuclear receptor signaling and immunometabolic controls. This article extends prior discussions in "LG 101506 and RXR Modulation: New Horizons in Nuclear Rec..." by providing updated quantitative benchmarks and workflow guidance for the compound.

Mechanism of Action of LG 101506

LG 101506 acts as a selective modulator of the RXR ligand-binding domain. Upon binding, it induces conformational changes that alter RXR's ability to recruit coactivators or corepressors, thus modulating gene expression. The chemical name of LG 101506 is (2E,4E,6Z)-7-(3,5-di-tert-butyl-2-(2,2-difluoroethoxy)phenyl)-3-methylocta-2,4,6-trienoic acid. It is an off-white solid with a molecular weight of 420.53 Da and a purity of 98.00% as verified by HPLC (APExBIO). The compound is soluble in DMSO up to 42.05 mg/ml and in ethanol up to 21.03 mg/ml at room temperature. LG 101506 is not intended for diagnostic or therapeutic use in humans or animals.

Evidence & Benchmarks

• LG 101506 enables the modulation of RXR activity, which is central to regulating PD-L1 expression and immune checkpoint function in cancer models (Zhang et al., 2022, DOI).
• In vitro, RXR modulation influences mRNA stability and glycosylation of PD-L1, affecting tumor immune evasion (DOI).
• LG 101506’s high solubility in DMSO (42.05 mg/ml) and ethanol (21.03 mg/ml) facilitates its use in a wide range of biochemical and cellular assays (APExBIO).
• Stability is preserved by shipping on blue or dry ice and storage at -20°C, preventing degradation and loss of activity (APExBIO).
• Published studies demonstrate that RXR pathway modulation is a promising approach for overcoming resistance to immune checkpoint blockade, particularly in immune-cold TNBC (DOI).

This article clarifies experimental boundaries and provides actionable workflow instructions beyond what is covered in "RXR Modulation as a Translational Frontier: Mechanistic I...", which focuses on translational implications and immune-cold tumor models.

Applications, Limits & Misconceptions

LG 101506 is optimized for research on RXR signaling, metabolism regulation, and nuclear receptor-driven processes. Its utility spans chemical biology, disease model exploration, and mechanistic immune checkpoint investigations. For advanced workflows, LG 101506 empowers precise pharmacological interrogation of RXR, supporting studies in both metabolic and cancer biology contexts (related article). This guide updates previous discussions by providing explicit solubility, storage, and workflow parameters for consistent results.

Common Pitfalls or Misconceptions

• Not for clinical or diagnostic use: LG 101506 is strictly for laboratory research. It is not approved for human or veterinary medical applications (APExBIO).
• Solution stability: Solutions of LG 101506 should not be stored long-term; prepare fresh solutions and use promptly for reproducibility.
• Temperature sensitivity: Incorrect storage above -20°C or repeated freeze-thaw cycles can lead to compound degradation and reduced efficacy.
• Model system limits: RXR modulation effects are context-dependent; results in cell lines may not translate directly to in vivo models without validation (Zhang et al., 2022).
• No direct PD-L1 inhibitor: LG 101506 modulates RXR, which can indirectly influence PD-L1 levels, but it is not a direct PD-L1 antagonist.

Workflow Integration & Parameters

• Preparation: Dissolve LG 101506 in DMSO (up to 42.05 mg/ml) or ethanol (up to 21.03 mg/ml) at room temperature. Vortex or sonicate if necessary for complete dissolution.
• Storage: Store powder at -20°C in a desiccated environment. Avoid light exposure to maintain chemical stability.
• Delivery: Compound is shipped by APExBIO on blue ice or dry ice, depending on form, to preserve activity during transit (APExBIO).
• Assay deployment: Use freshly prepared solutions in biochemical, cell-based, or reporter assays targeting RXR signaling. Validate concentration ranges for each experimental system.
• Controls: Employ vehicle controls (DMSO or ethanol) at matching concentrations to rule out solvent effects.

This workflow enables direct comparison to alternative RXR modulators and supports troubleshooting for resistant disease models, as detailed in "LG 101506: Precision RXR Modulator for Nuclear Receptor R...".

Conclusion & Outlook

LG 101506 is a characterized, high-purity RXR modulator optimized for academic and pharmaceutical research. It provides robust performance in RXR signaling pathway research, offering insights into metabolism regulation, immune checkpoints, and nuclear receptor-driven diseases. By following validated handling and assay recommendations, researchers can maximize the reproducibility and impact of their RXR-centric studies. APExBIO continues to support scientific discovery by providing rigorously tested reagents such as LG 101506 (product page).